NHS National Framework Agreement for the supply of products for the management of Hereditary Angioedema. Period of framework agreement: 1 July 2022 to 31 December 2023 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 30 months. Total maximum framework agreement including extension options will be no more than 48 months
- Procurement
- Hereditary Angioedema
- Buyer
- NHS England
- Published
- 20 Jul 2022
- Status
- complete
- CPV
- 33600000 — Pharmaceutical products
- Tender period
- — – 16 Mar 2022
Awards
Other notices in this procurement
This is the only notice on record.
FAQs about this notice
What type of notice is this?
This is a award notice published via Contracts Finder on 20 Jul 2022.
Which procurement does this notice belong to?
It is part of "Hereditary Angioedema", published by NHS England.
Has this notice resulted in an award?
10 awards are recorded on this notice, including to Martindale Pharma.
Get the full procurement picture
Enable turns the UK's public-contract data into pipeline intelligence for bid and capture teams. Talk to us about access, alerts and tailored market analysis.
Get in touch with Enable